Chemomab Therapeutics (CMMB) Set to Announce Quarterly Earnings on Wednesday

Chemomab Therapeutics (NASDAQ:CMMB) will announce its earnings results before the market opens on Wednesday, August 21st. Analysts expect the company to announce earnings of ($0.20) per share for the quarter.

Chemomab Therapeutics Trading Up 10.9 %

Shares of CMMB stock opened at $1.05 on Wednesday. Chemomab Therapeutics has a 12 month low of $0.42 and a 12 month high of $1.58. The company has a market capitalization of $11.60 million, a P/E ratio of -0.66 and a beta of 0.50. The stock has a 50 day moving average of $1.06 and a two-hundred day moving average of $0.86.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on CMMB shares. Oppenheimer raised Chemomab Therapeutics from a “market perform” rating to an “outperform” rating and set a $6.00 target price for the company in a research report on Monday, May 6th. Maxim Group raised shares of Chemomab Therapeutics to a “strong-buy” rating in a report on Friday, May 24th.

About Chemomab Therapeutics

Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, discovers and develops therapeutics for the treatment of fibrotic and inflammatory diseases. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody had completed Phase 2a clinical trials that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc).